Clenergen Corporation was pleased to announce this morning that it has closed the previously announced share exchange agreement with Clenergen Corporation Limited, a United Kingdom Corporation (”Clenergen UK”). As previously agreed upon, the company issued 13,643,045 restricted shares of its common stock to the former shareholders of Clenergen UK.

Clenergen was also pleased to announce that it has appointed Dr. Arvind Pandalai, Mr. Robert Kohn, Mr. David Sonnenberg, Mr. Mike Starkie, Mr Dale Shepherd and Mr. Jack Dickey to its board of directors. Details regarding the closing of the share exchange agreement can be found in the company’s continuous disclosure documents as filed on www.sec.gov.

Let us hear your thoughts: Clenergen Corporation Message Board

Today it was announced that Clenergen Corporation India Private Limited, a wholly owned subsidiary of Clenergen Corporation, has agreed on the terms to acquire a 1.5MW/Hr biomass power plant in Namakkal, Tamilnadu, which will be operational by yearend 2009.

Recognized as one of India’s National Demonstration Projects, the plant was shut down in 2007 due to operational cash flow constraints and its inability to remain profitable at a low tariff rate. However, under a Power Purchase Agreement between Power Trading Corporation of India Limited (PTC) and Clenergen India Private Limited, a higher tariff rate has now been agreed.

The unit is expected to generate net revenue of approximately US$1 million in its first year of operation. During the first phase of its operations in India, Clenergen will ramp up the capacity of this power plant to 10MW/Hr while installing two new biomass

Clenergen Corp. is a biofuels company that is approaching the sector from a different perspective – from an agronomy/biology and plantation standpoint. The company’s goal is to produce high-density, short-rotation biomass crops on a commercial scale which will then be used to power, steam and perhaps produce other products from advanced gasification and steam technologies.

The company is led by an eminent Board of Directors and Advisors. Here is a brief overview of the members:

Dr. Arvind Pandalai – Non-Executive Group Chairman

Dr. Pandalai has 32 years of experience in international trading, export and import management, joint ventures, project and financial management along with strategic planning. He has numerous prestigious management awards in his native India.

Robert Kohn – Non-Executive Vice-Chairman, North America

Mr. Kohn has been chairman/CEO, president/COO, and co-founder of three start-up public companies, with a combined market cap of over $1.5 billion.

Today, Clenergen Corp. announced that it has received approval from Madurai Kamaraj University, a respected University established in 1966, to inititate a research project on behalf of Clenergen to develop and apply new scientific techniques to enhance growth of biomass crops and to develop superior agronomical practices for best possible utilization of available natural resources to maximize yield.

Clenergen told investors today that it has accepted the terms of the technical engagement and that the project will commence during the first week of October 2009. The Department of Bioenergy, School of Energy, Environment and Natural Resources of the University will execute the project for Clenergen. Currently, Dr K. Muthuchelian is currently Director for Biodiversity and Forest Studies at the Madurai Kamaraj University, and Professor and Head of the School of Energy, Environment and Natural Resources at Madurai Kamaraj University, Madurai.

Prof. K. Muthuchelian

Earlier this year, Clenergen Corp. announced its first major power purchase agreement with the Power Trading Corporation (NASDAQ: PTC) of India for the purchase and sale of 71 MW of power, which is to be generated by Clenergen’s new biomass based power project in Tamilnadu. This purchase agreement has a value of up to $80.0 MM USD per year for 15 years, totaling to $1.2 Billion.

Clenergen India’s Honorary Chairman Dr. Arvind Pandalai, who has helped formulate various policies of the Government of India over a 32 year career, believes that his home country is the ideal place for Clenergen to initiate its global agenda. He stated, “The expertise of Clenergen’s management team and the strength of its proposition at a time when India and the rest of the world is demanding cleaner, more accessible electricity are truly compelling.”

The residential and business

Today, Clenergen Corporation announced that it will acquire 100% controlling interest of UK-based Clenergen Corporation Limited, intending to establish the corporation as a global leader of Biomass Power Generation Companies.

CCL currently retains 100% controlling interest in Clenergen India Private Limited, a subsidiary company based in Chennai, designed to implement a 80MW per hour Biomass Power Plant. Recently, Clenergen India signed a 15 year Power Purchase Agreement with the Power Trading Corporation of India Limited, valued at $87,000,000 per year. The company has secured leases on 4000 acres of land in Tamilnadu and is in the process of obtaining land leases from the Government of Karnataka to cultivate 25,000 acres for the production of biomass from bamboo cultivation. Clenergen India is projected to float on the National Stock Exchange in India in December 2009 and intends to have engaged Ernst and Young to raise its debt and private equity requirements.

In